The Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization, is focused on developing earlier diagnoses and smarter treatments. Translational genomics research employs innovative advances arising from the Human Genome Project by applying them to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes and other complex diseases. TGen’s research is based on personalized medicine and the institute plans to accomplish its goals through robust and disease-focused research.